Clinical Trial

Evaluation of Low-thermal Argon Plasma Devitalization for the Treatment of CIN 2 Versus Standard of Active Surveillance

Study acronym: CINPLASTA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to show that treatment with LtAPD works better than a sham treatment or simply monitoring the condition closely without active treatment ("active surveillance"), in achieving complete healing of a tissue abnormality on the cervix called CIN 2, after 6 months. This will be confirmed by examining tissue samples under a microscope (histopathological examination).
Trial Details
NCT Number NCT07730645
Lead Sponsor University Hospital Tuebingen
Conditions Cervical Intraepithelial Neoplasia Grade 2 (CIN2), Cervical Intraepithelial Neoplasia Grade 2, CIN2
Enrollment 264 participants
Start Date 2026-08-17
Primary Completion 2029-03-31 (estimated)
Study Completion 2029-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-03